Linked Life Data

1928339

Source:http://linkedlifedata.com/resource/pubmed/id/1928339

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1928339rdf:typepubmed:Citationlld:pubmed
pubmed-article:1928339lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:1928339lifeskim:mentionsumls-concept:C2347026lld:lifeskim
pubmed-article:1928339lifeskim:mentionsumls-concept:C0370003lld:lifeskim
pubmed-article:1928339lifeskim:mentionsumls-concept:C0023779lld:lifeskim
pubmed-article:1928339lifeskim:mentionsumls-concept:C1327616lld:lifeskim
pubmed-article:1928339lifeskim:mentionsumls-concept:C0001026lld:lifeskim
pubmed-article:1928339lifeskim:mentionsumls-concept:C0577559lld:lifeskim
pubmed-article:1928339lifeskim:mentionsumls-concept:C1509144lld:lifeskim
pubmed-article:1928339lifeskim:mentionsumls-concept:C0037775lld:lifeskim
pubmed-article:1928339lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:1928339lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:1928339lifeskim:mentionsumls-concept:C0337051lld:lifeskim
pubmed-article:1928339pubmed:issue4 Pt 1lld:pubmed
pubmed-article:1928339pubmed:dateCreated1991-11-18lld:pubmed
pubmed-article:1928339pubmed:abstractTextMeasurement of hepatic fatty acid (FA) and cholesterol synthesis has been limited by lack of access to the precursor pool, cytosolic acetyl-CoA. We present a method for inferring the enrichment of the true hepatic lipogenic precursor pool in humans using the frequency distribution of mass isotopomers within enriched circulating polymers of acetyl-CoA [very low-density lipoprotein (VLDL)-palmitate, VLDL-stearate]. Human subjects were infused intravenously (n = 16) with [1-13C]- or [2-13C]acetate. Oral sulfamethoxazole (SMX) was administered concurrently, and the acetylated conjugate (SMX acetate) was used to estimate independently the hepatic cytosolic acetyl-CoA enrichment. Isotopomer frequencies in VLDL-FA were determined by gas chromatography-mass spectrometry, whereas high-performance liquid chromatography-mass spectrometry was used to measure enrichments in SMX acetate. Based on the excess M2/excess M1 ratio in VLDL-FA, calculated acetyl-CoA enrichments were 5.59 +/- 0.33 molar percent excess (MPE), whereas SMX acetate enrichments were 5.38 +/- 0.31 MPE (the 2 methods were not significantly different). Mass isotopomer-calculated and SMX acetate-measured estimates of acetyl-CoA enrichments correlated very closely in individual subjects (r2 = 0.93; P less than 0.0001). De novo hepatic lipogenesis can be measured using isotopomer-calculated precursor enrichments compared with measured incorporation in specific isotopomers of VLDL-FA. In summary, excess isotopomer frequencies in secreted lipids provide a non-invasive technique for estimating hepatic cytosolic acetyl-CoA enrichments in humans in vivo and correlate closely with enrichments observed using the xenobiotic probe technique. Isotopomeric distributions represent a new strategy for accurate measurement of macromolecule synthesis that may be applicable to other classes of molecules besides lipids.lld:pubmed
pubmed-article:1928339pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1928339pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1928339pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1928339pubmed:languageenglld:pubmed
pubmed-article:1928339pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1928339pubmed:citationSubsetIMlld:pubmed
pubmed-article:1928339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1928339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1928339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1928339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1928339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1928339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1928339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1928339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1928339pubmed:statusMEDLINElld:pubmed
pubmed-article:1928339pubmed:monthOctlld:pubmed
pubmed-article:1928339pubmed:issn0002-9513lld:pubmed
pubmed-article:1928339pubmed:authorpubmed-author:WuKKlld:pubmed
pubmed-article:1928339pubmed:authorpubmed-author:ShackletonC...lld:pubmed
pubmed-article:1928339pubmed:authorpubmed-author:HellersteinM...lld:pubmed
pubmed-article:1928339pubmed:authorpubmed-author:KaempferSSlld:pubmed
pubmed-article:1928339pubmed:authorpubmed-author:KletkeCClld:pubmed
pubmed-article:1928339pubmed:issnTypePrintlld:pubmed
pubmed-article:1928339pubmed:volume261lld:pubmed
pubmed-article:1928339pubmed:ownerNLMlld:pubmed
pubmed-article:1928339pubmed:authorsCompleteYlld:pubmed
pubmed-article:1928339pubmed:paginationE479-86lld:pubmed
pubmed-article:1928339pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:1928339pubmed:meshHeadingpubmed-meshheading:1928339-...lld:pubmed
pubmed-article:1928339pubmed:meshHeadingpubmed-meshheading:1928339-...lld:pubmed
pubmed-article:1928339pubmed:meshHeadingpubmed-meshheading:1928339-...lld:pubmed
pubmed-article:1928339pubmed:meshHeadingpubmed-meshheading:1928339-...lld:pubmed
pubmed-article:1928339pubmed:meshHeadingpubmed-meshheading:1928339-...lld:pubmed
pubmed-article:1928339pubmed:meshHeadingpubmed-meshheading:1928339-...lld:pubmed
pubmed-article:1928339pubmed:meshHeadingpubmed-meshheading:1928339-...lld:pubmed
pubmed-article:1928339pubmed:meshHeadingpubmed-meshheading:1928339-...lld:pubmed
pubmed-article:1928339pubmed:meshHeadingpubmed-meshheading:1928339-...lld:pubmed
pubmed-article:1928339pubmed:meshHeadingpubmed-meshheading:1928339-...lld:pubmed
pubmed-article:1928339pubmed:meshHeadingpubmed-meshheading:1928339-...lld:pubmed
pubmed-article:1928339pubmed:meshHeadingpubmed-meshheading:1928339-...lld:pubmed
pubmed-article:1928339pubmed:meshHeadingpubmed-meshheading:1928339-...lld:pubmed
pubmed-article:1928339pubmed:year1991lld:pubmed
pubmed-article:1928339pubmed:articleTitleUse of mass isotopomer distributions in secreted lipids to sample lipogenic acetyl-CoA pool in vivo in humans.lld:pubmed
pubmed-article:1928339pubmed:affiliationDepartment of Nutritional Sciences, University of California, Berkeley 94720.lld:pubmed
pubmed-article:1928339pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1928339pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:1928339pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1928339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1928339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1928339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1928339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1928339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1928339lld:pubmed